Publication archives

Nanotechnology and its applications are so small that it can be hard to get your head around, but there are more than 1,000 products with nanomaterials already on the market, so we'd better get a handle on this quick. 
Discussion on the link between antibiotic resistance in humans and the routine, subtherapeutic use of antibiotics in food animal production rolls on. For the past several weeks, congressional staff working on food, agriculture, and health issues have heard from both both sides of the debate with a series of briefings on the issue.
After official UN global climate talks stumbled again in Bonn last week, another global gathering will take a shot at reaching agreement on a plan to address climate change.
This blog entry is re-posted, with permission, from Healthy Legacy, a coalition promoting healthy lives by supporting the production and use of everyday products without toxic chemicals. IATP is a member of Healthy Legacy's steering committee.
by
Karen Hansen-Kuhn
Any international negotiations or initiatives on climate change and agriculture must begin with recognition of the multifunctionality of agriculture. It is not just one more sector.
Infectious disease doctors, public health experts and scientific researchers met with Congressional leaders and staff on Wednesday to describe how the routine non-therapeutic use of human antibiotics in the food and water of livestock results in antibiotic-resistant diseases in humans that cause extended hospital stays and increase health care costs.
by
Shiney Varghese
Which obligations do States bear in the context of private sector participation in the provision of water and sanitation services? What should the regulatory framework put into place by States provide for? Apart from regulation, what additional measures, structures and institutions are necessary?
IATP's Dr. Steve Suppan testified before the Hearing on Nanotechnologies, Housing and Public Health Committee at the Minnesota House of Representatives. He shared IATP's views about some of general regulatory and legislative challenges presented by nanotechnologies.